Will Zepbound Overtake Wegovy in New US Prescriptions for 2025?
4,066 Vol.4 months ago (Mar-14-2026 03:59:00 AM UTC)
DescriptionWill Eli Lilly’s Zepbound have more new prescriptions than Novo Nordisk’s Wegovy in the US for the entire year of 2025? With both drugs gaining popularity, bet on which one will lead in new patient starts. Settlement Criteria: Settles to "Yes" if credible sources confirm that Zepbound has more new prescriptions than Wegovy in the US for the calendar year 2025. Primary Sources: IQVIA data, company reports, or consensus from pharmaceutical news outlets like Reuters, Forbes, or FiercePharma. The Event Outcome is a Prediction on an Announcement from a credible reporting source.